1887

Abstract

are a leading cause of healthcare-associated infections worldwide. In particular, strains expressing extended-spectrum β-lactamases (ESBLs) and carbapenemases pose serious treatment challenges, leading the World Health Organization (WHO) to designate ESBL and carbapenem-resistant Enterobacteriaceae as ‘critical’ threats to human health. Research efforts to combat these pathogens can be supported by accessibility to diverse and clinically relevant isolates for testing novel therapeutics. Here, we describe a panel of 100 diverse isolates that are publicly available to assist the research community in this endeavour. Whole-genome sequencing (WGS) was performed on 3878 . clinical isolates housed at the Multidrug-Resistant Organism Repository and Surveillance Network. The isolates were cultured from 63 facilities in 19 countries between 2001 and 2020. Core-genome multilocus sequence typing and high-resolution single-nucleotide polymorphism-based phylogenetic analyses captured the genetic diversity of the collection and were used to select the final panel of 100 isolates. In addition to known multidrug-resistant (MDR) pandemic lineages, the final panel includes hypervirulent lineages and isolates with specific and diverse resistance genes and virulence biomarkers. A broad range of antibiotic susceptibilities, ranging from pan-sensitive to extensively drug-resistant isolates, are described. The panel collection, and all associated metadata and genome sequences, are available at no additional cost and will be an important resource for the research community and for the design and development of novel antimicrobial agents and diagnostics against this important pathogen.

Funding
This study was supported by the:
  • Medical Research and Materiel Command (Award P0140_20_WR_04)
    • Principle Award Recipient: PatrickT Mc Gann
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000967
2023-05-04
2024-11-02
Loading full text...

Full text loading...

/deliver/fulltext/mgen/9/5/mgen000967.html?itemId=/content/journal/mgen/10.1099/mgen.0.000967&mimeType=html&fmt=ahah

References

  1. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11:589–603 [View Article]
    [Google Scholar]
  2. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D et al. Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of America. Clin Infect Dis 2009; 48:1–12 [View Article]
    [Google Scholar]
  3. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019; 19:56–66 [View Article] [PubMed]
    [Google Scholar]
  4. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399:629–655 [View Article]
    [Google Scholar]
  5. Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev 2017; 41:252–275 [View Article]
    [Google Scholar]
  6. Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol 2020; 18:344–359 [View Article]
    [Google Scholar]
  7. Chen L, Todd R, Kiehlbauch J, Walters M, Kallen A. Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae - Washoe County, Nevada, 2016. MMWR Morb Mortal Wkly Rep 2017; 66:33 [View Article]
    [Google Scholar]
  8. World Health Organization Prioritization of pathogens to guide resistant bacterial infections, including tuberculosis. Switzerland: Geneva; 2017
  9. Shon AS, Bajwa RPS, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 2013; 4:107–118 [View Article]
    [Google Scholar]
  10. Lam MMC, Wyres KL, Duchêne S, Wick RR, Judd LM et al. Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination. Nat Commun 2018; 9:2703 [View Article]
    [Google Scholar]
  11. Nassif X, Sansonetti PJ. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infect Immun 1986; 54:603–608 [View Article]
    [Google Scholar]
  12. Martin MJ, Corey BW, Sannio F, Hall LR, MacDonald U. Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy. Proc Natl Acad Sci 2021; 118:e2110227118 [View Article]
    [Google Scholar]
  13. Gu D, Dong N, Zheng Z, Lin D, Huang M et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 2018; 18:37–46 [View Article]
    [Google Scholar]
  14. Wyres KL, Nguyen TNT, Lam MMC, Judd LM, van Vinh Chau N et al. Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. Genome Med 2020; 12:11 [View Article]
    [Google Scholar]
  15. Gonzalez-Ferrer S, Peñaloza HF, Budnick JA, Bain WG, Nordstrom HR et al. Finding order in the chaos: outstanding questions in Klebsiella pneumoniae pathogenesis. Infect Immun 2021; 89:e00693-20 [View Article]
    [Google Scholar]
  16. Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci 2015; 112:E3574–81 [View Article]
    [Google Scholar]
  17. David S, Reuter S, Harris SR, Glasner C, Feltwell T et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol 2019; 4:1919–1929 [View Article]
    [Google Scholar]
  18. Marsh JW, Mustapha MM, Griffith MP, Evans DR, Ezeonwuka C et al. Evolution of outbreak-causing carbapenem-resistant Klebsiella pneumoniae ST258 at a tertiary care hospital over 8 years. mBio 2019; 10:e01945-19 [View Article]
    [Google Scholar]
  19. Shropshire WC, Dinh AQ, Earley M, Komarow L, Panesso D et al. Accessory genomes drive independent spread of carbapenem-resistant Klebsiella pneumoniae clonal groups 258 and 307 in Houston, TX. mBio 2022; 13:e0049722 [View Article]
    [Google Scholar]
  20. Heiden SE, Hübner N-O, Bohnert JA, Heidecke C-D, Kramer A et al. A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition. Genome Med 2020; 12:113 [View Article]
    [Google Scholar]
  21. Falcone M, Giordano C, Barnini S, Tiseo G, Leonildi A et al. Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020. Euro Surveill 2020; 25:6 [View Article] [PubMed]
    [Google Scholar]
  22. Wyres KL, Wick RR, Judd LM, Froumine R, Tokolyi A et al. Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae. PLoS Genet 2019; 15:e1008114 [View Article]
    [Google Scholar]
  23. Waterman P, Kwak Y, Clifford R, Julius M, Onmus-Leone F et al. A multidrug-resistance surveillance network: 1 year on. Lancet Infect Dis 2012; 12:587–588 [View Article] [PubMed]
    [Google Scholar]
  24. Galac MR, Snesrud E, Lebreton F, Stam J, Julius M et al. A diverse panel of clinical Acinetobacter baumannii for research and development. Antimicrob Agents Chemother 2020; 64:e00840-20 [View Article]
    [Google Scholar]
  25. Lebreton F, Snesrud E, Hall L, Mills E, Galac M et al. A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development. JAC Antimicrob Resist 2021; 3:dlab179 [View Article]
    [Google Scholar]
  26. Clinical and Laboratory Standards Institute Method for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 11th edn. Clin Lab Stand Inst; 2018
    [Google Scholar]
  27. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article] [PubMed]
    [Google Scholar]
  28. Lam MMC, Wick RR, Watts SC, Cerdeira LT, Wyres KL et al. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat Commun 2021; 12:4188 [View Article]
    [Google Scholar]
  29. Feldgarden M, Brover V, Haft DH, Prasad AB, Slotta DJ et al. Validating the AMRFinder tool and resistance gene database by using antimicrobial resistance genotype-phenotype correlations in a collection of isolates. Antimicrob Agents Chemother 2019; 63:e00483-19 [View Article]
    [Google Scholar]
  30. Hunt M, Mather AE, Sánchez-Busó L, Page AJ, Parkhill J et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microb Genom 2017; 3:e000131 [View Article]
    [Google Scholar]
  31. Jünemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U et al. Updating benchtop sequencing performance comparison. Nat Biotechnol 2013; 31:294–296 [View Article] [PubMed]
    [Google Scholar]
  32. Laing C, Buchanan C, Taboada EN, Zhang Y, Kropinski A et al. Pan-genome sequence analysis using Panseq: an online tool for the rapid analysis of core and accessory genomic regions. BMC Bioinformatics 2010; 11:461 [View Article] [PubMed]
    [Google Scholar]
  33. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014; 30:1312–1313 [View Article] [PubMed]
    [Google Scholar]
  34. Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol 2019; 20:257 [View Article] [PubMed]
    [Google Scholar]
  35. Low AJ, Koziol AG, Manninger PA, Blais B, Carrillo CD. ConFindr: rapid detection of intraspecies and cross-species contamination in bacterial whole-genome sequence data. PeerJ 2019; 7:e6995 [View Article]
    [Google Scholar]
  36. Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015; 31:3691–3693 [View Article] [PubMed]
    [Google Scholar]
  37. Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43:4178–4182 [View Article]
    [Google Scholar]
  38. Lam MMC, Wick RR, Judd LM, Holt KE, Wyres KL. Kaptive 2.0: updated capsule and lipopolysaccharide locus typing for the Klebsiella pneumoniae species complex. Microb Genom 2022; 8:000800 [View Article]
    [Google Scholar]
  39. Follador R, Heinz E, Wyres KL, Ellington MJ, Kowarik M et al. The diversity of Klebsiella pneumoniae surface polysaccharides. Microb Genom 2016; 2:e000073 [View Article]
    [Google Scholar]
  40. Lam MMC, Wick RR, Wyres KL, Gorrie CL, Judd LM et al. Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element icekp in Klebsiella pneumoniae populations. Microb Genomics 2018; 4:
    [Google Scholar]
  41. Corkill JE, Cuevas LE, Gurgel RQ, Greensill J, Hart CA. SHV-27, a novel cefotaxime-hydrolysing beta-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital. J Antimicrob Chemother 2001; 47:463–465 [View Article]
    [Google Scholar]
  42. Wise MG, Horvath E, Young K, Sahm DF, Kazmierczak KM. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases. J Med Microbiol 2018; 67:289–295 [View Article]
    [Google Scholar]
  43. Jacoby GA. AmpC β-Lactamases. Clin Microbiol Rev 2009; 22:161–182 [View Article]
    [Google Scholar]
  44. Centers for Disease Control and Prevention (U.S) Antibiotic Resistance Threats in the United States, 2019 Centers for Disease Control and Prevention (U.S); 2019
    [Google Scholar]
  45. The White House National Action Plan For Combating Antibiotic-Resistant Bacteria Washington, DC: The White House; 2015
    [Google Scholar]
  46. Brennan-Krohn T, Kirby JE. Synergistic combinations and repurposed antibiotics active against the pandrug-resistant Klebsiella pneumoniae Nevada strain. Antimicrob Agents Chemother 2019; 63:e01374-19 [View Article]
    [Google Scholar]
  47. Opoku-Temeng C, Kobayashi SD, DeLeo FR. Klebsiella pneumoniae capsule polysaccharide as a target for therapeutics and vaccines. Comput Struct Biotechnol J 2019; 17:1360–1366 [View Article] [PubMed]
    [Google Scholar]
  48. Laforêt F, Antoine C, Blasdel Reuter B, Detilleux J, Pirnay J-P et al. In vitro and in vivo assessments of two newly isolated bacteriophages against an ST13 urinary tract infection Klebsiella pneumoniae. Viruses 2022; 14:1079 [View Article]
    [Google Scholar]
  49. Pathogen genomics leading to vaccines. Nat Genet 2019; 51:923 [View Article]
    [Google Scholar]
  50. Lourenço M, Osbelt L, Passet V, Gravey F, Strowig T et al. Phages against non-capsulated Klebsiella pneumoniae: broader host range, slower resistance. Microbiology 2022 [View Article]
    [Google Scholar]
  51. Hesse S, Rajaure M, Wall E, Johnson J, Bliskovsky V et al. Phage resistance in multidrug-resistant Klebsiella pneumoniae ST258 evolves via diverse mutations that culminate in impaired adsorption. mBio 2020; 11:e02530-19 [View Article]
    [Google Scholar]
  52. Orskov I, Fife-asbury MA. New Klebsiella capsular antigen, K82, and the deletion of five of those previously assigned. Int J Syst Bacteriol 1977; 27:386–387 [View Article]
    [Google Scholar]
  53. Clarke BR, Ovchinnikova OG, Kelly SD, Williamson ML, Butler JE et al. Molecular basis for the structural diversity in serogroup O2-antigen polysaccharides in Klebsiella pneumoniae. J Biol Chem 2018; 293:4666–4679 [View Article] [PubMed]
    [Google Scholar]
  54. Russo TA, MacDonald U, Hassan S, Camanzo E, LeBreton F et al. An assessment of siderophore production, mucoviscosity, and mouse infection models for defining the virulence spectrum of hypervirulent Klebsiella pneumoniae. mSphere 2021; 6:e00045-21 [View Article]
    [Google Scholar]
  55. Kiaei S, Moradi M, hosseini-nave H, Ziasistani M, Kalantar-Neyestanaki D. Endemic dissemination of different sequence types of carbapenem-resistant klebsiella pneumoniae strains harboring blandmand16s rrna methylase genes in Kerman hospitals, Iran, from 2015 to 2017. Infect Drug Resist 2018; 12:45–54
    [Google Scholar]
  56. Kim M-N, Yong D, An D, Chung H-S, Woo JH et al. Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital. J Clin Microbiol 2012; 50:1433–1436 [View Article]
    [Google Scholar]
  57. Al-Quraini M, Rizvi M, Al-Jabri Z, Sami H, Al-Muzahmi M et al. Assessment of in-vitro synergy of fosfomycin with meropenem, amikacin and tigecycline in whole genome sequenced extended and pan drug resistant Klebsiella Pneumoniae: exploring a colistin sparing protocol. Antibiotics 2022; 11:153 [View Article]
    [Google Scholar]
  58. Pragasam AK, Shankar C, Veeraraghavan B, Biswas I, Nabarro LEB et al. Molecular mechanisms of colistin resistance in Klebsiella pneumoniae causing bacteremia from India-a first report. Front Microbiol 2016; 7:2135 [View Article]
    [Google Scholar]
  59. Gorrie CL, Mirčeta M, Wick RR, Judd LM, Lam MMC et al. Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen. Nat Commun 2022; 13:3017 [View Article]
    [Google Scholar]
  60. Klaper K, Hammerl JA, Rau J, Pfeifer Y, Werner G. Genome-based analysis of Klebsiella spp isolates from animals and food products in Germany, 2013–2017. Pathogens 2021; 10:573 [View Article]
    [Google Scholar]
  61. Lioy VS, Goussard S, Guerineau V, Yoon E-J, Courvalin P et al. Aminoglycoside resistance 16S rRNA methyltransferases block endogenous methylation, affect translation efficiency and fitness of the host. RNA 2014; 20:382–391 [View Article] [PubMed]
    [Google Scholar]
  62. Bontron S, Poirel L, Nordmann P. In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity. Antimicrob Agents Chemother 2015; 59:1664–1670 [View Article] [PubMed]
    [Google Scholar]
  63. Jeong SH, Bae IK, Kim D, Hong SG, Song JS et al. First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum beta-lactamases in Korea. Antimicrob Agents Chemother 2005; 49:4809–4810 [View Article]
    [Google Scholar]
  64. Chen D-Q, Wu A-W, Yang L, Su D-H, Lin Y-P et al. Emergence and plasmid analysis of Klebsiella pneumoniae KP01 carrying blaGES-5 from Guangzhou, China. Antimicrob Agents Chemother 2016; 60:6362–6364 [View Article]
    [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.000967
Loading
/content/journal/mgen/10.1099/mgen.0.000967
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Supplementary material 3

EXCEL

Supplementary material 4

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error